Changes in CD38 expression
| ID no. . | M . | CD38 (%) . | M . | CD38 (%) . | M . | CD38 (%) . | M . | CD38 (%) . | M . | CD38 (%) . | M . | CD38 (%) . | S/P . |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 185 | 0 | 30.6 | 38 | 37.2 | 52 | 34.2 | 81 | 39.0 | 89 | 42.9 | 97 | 44.5 | Ap |
| 29 | 0 | 76.5 | 25 | 84.8 | 29 | 86.3 | 31 | 91.6 | — | — | — | — | Ap |
| 37 | 0 | 4.2 | 37 | 9.8 | 50 | 10.4 | 52 | 12.7 | 53 | 27.6 | — | — | Ap |
| 20 | 0 | 54.4 | 8 | 47.8 | 18 | 77.5 | — | — | — | — | — | — | Ap |
| 143 | 0 | 11.2 | 8 | 58.7 | 14 | 72.2 | — | — | — | — | — | — | As |
| 157 | 0 | 4.8 | 21 | 0.7 | 24 | 10.2 | 54 | 14.3 | — | — | — | — | As |
| 12 | 0 | 3.8 | 31 | 13.1 | 37 | 28.1 | 45 | 32.7 | 52 | 29.9 | 55 | 54.8 | Ap |
| 144 | 0 | 45.0 | 3 | 72.6 | — | — | — | — | — | — | — | — | Bp |
| 125 | 0 | 21.6 | 14 | 25.2 | 23 | 6.6 | — | — | — | — | — | — | Bp |
| 25 | 0 | 41.8 | 4 | 50.1 | 28 | 25.6 | 40 | 28.5 | 53 | 28.6 | — | — | Ap |
| ID no. . | M . | CD38 (%) . | M . | CD38 (%) . | M . | CD38 (%) . | M . | CD38 (%) . | M . | CD38 (%) . | M . | CD38 (%) . | S/P . |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 185 | 0 | 30.6 | 38 | 37.2 | 52 | 34.2 | 81 | 39.0 | 89 | 42.9 | 97 | 44.5 | Ap |
| 29 | 0 | 76.5 | 25 | 84.8 | 29 | 86.3 | 31 | 91.6 | — | — | — | — | Ap |
| 37 | 0 | 4.2 | 37 | 9.8 | 50 | 10.4 | 52 | 12.7 | 53 | 27.6 | — | — | Ap |
| 20 | 0 | 54.4 | 8 | 47.8 | 18 | 77.5 | — | — | — | — | — | — | Ap |
| 143 | 0 | 11.2 | 8 | 58.7 | 14 | 72.2 | — | — | — | — | — | — | As |
| 157 | 0 | 4.8 | 21 | 0.7 | 24 | 10.2 | 54 | 14.3 | — | — | — | — | As |
| 12 | 0 | 3.8 | 31 | 13.1 | 37 | 28.1 | 45 | 32.7 | 52 | 29.9 | 55 | 54.8 | Ap |
| 144 | 0 | 45.0 | 3 | 72.6 | — | — | — | — | — | — | — | — | Bp |
| 125 | 0 | 21.6 | 14 | 25.2 | 23 | 6.6 | — | — | — | — | — | — | Bp |
| 25 | 0 | 41.8 | 4 | 50.1 | 28 | 25.6 | 40 | 28.5 | 53 | 28.6 | — | — | Ap |
ID no. refers to the sequence of investigation among 243 patients tested for IgVH mutations or CD38 expression.
M indicates number of months from presentation; S/P, Binet stage of disease at diagnosis and pace of the disease, either stable (s) or progressive (p).